Literature DB >> 24133564

Coexistence of aplasia cutis congenita, faun tail nevus and fetus papyraceus.

Pelin Ustüner1, Nursel Dilek, Yunus Saral, Işık Ustüner.   

Abstract

BACKGROUND: Aplasia cutis congenita is a disorder of the skin embryonic development characterized by a defect of localized or widespread areas of skin at birth. The lesions are mostly oval, 1-3 cm in diameter, with localization on the parietal part of scalp (60%) and rarely on the face and extremities. MAIN OBSERVATIONS: Herein, we reported a case of aplasia cutis congenita termly born at 39 weeks of gestation to a 30-year-old mother with bronchial asthma attacks. She was referred for 3 punched-out punctate depressed defective lesions in 0.4 cm's diameter on the vertex covered with necrotic and hemorrhagic crusts. There was a hypertrichotic area consisting of tufts of terminal hair on the lumbosacral area over a sinus tract. Maternal perinatal drugs included aerosol salbutamol sulfate, ipratropium bromide and oral montelukast sodium for bronchial asthma. The pregnancy was firstly started as a di-chorionic, di-amniotic twin gestation, but deteriorated after the fetal resorption of the co-twin in the 20th gestational week resulting in fetus papyraceus.
CONCLUSION: In multi-gestational pregnancies, the presence of the fetus papyraceus or the death of the co-twins should make the neonatologists and dermatologists be aware of the possible cutaneous defects like aplasia cutis congenita. We emphasize that the possibility of this rare entity should be kept in mind in the presence of fetus papyraceus, perinatal drug use, maternal cigarette smoke, or maternal diseases like bronchial asthma in multiple gestations.

Entities:  

Keywords:  alopecia; aplasia cutis congenita; bronchial asthma; cigarette smoking; faun tail naevus; fetus papyraceus; ipratropium; montelukast; nevoid hypertrichosis; salbutamol

Year:  2013        PMID: 24133564      PMCID: PMC3797017          DOI: 10.3315/jdcr.2013.1148

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  18 in total

1.  Idiopathic thoracolumbar syrinx with cutaneous marker.

Authors:  M A Mittler; J G McComb
Journal:  Pediatr Neurosurg       Date:  1999-02       Impact factor: 1.162

2.  Faun tail with aplasia cutis congenita and diastematomyelia.

Authors:  Emel Calikoğlu; Pinar Oztaş; Rana Yavuzer Anadolu; Ferhat Catal; Canan Görpelioğlu
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

Review 3.  Aplasia cutis congenita associated with coarctation of the aorta: case report and review of the literature.

Authors:  Isam M Lataifeh; Wadah M Khriesat; Eyad B Baqain; Firas A Al Qarqaz; Faisal Abuekteish
Journal:  Int J Dermatol       Date:  2009-11       Impact factor: 2.736

4.  Aplasia cutis congenita with hair collar sign and dermal melanocytosis.

Authors:  Ah-Young Cho; Sang-Sin Lee; Young Lee; Chang-Deok Kim; Jeung-Hoon Lee; Young-Joon Seo
Journal:  Int J Dermatol       Date:  2011-02-23       Impact factor: 2.736

5.  Maternal bronchodilator use and the risk of orofacial clefts.

Authors:  JeanPierre W Munsie; Shao Lin; Marilyn L Browne; Kimberly A Campbell; Alissa R Caton; Erin M Bell; Sonja A Rasmussen; Paul A Romitti; Charlotte M Druschel
Journal:  Hum Reprod       Date:  2011-09-15       Impact factor: 6.918

Review 6.  Clinical aspects of congenital skin defects. I. Congenital skin defects on the head of the newborn.

Authors:  U Demmel
Journal:  Eur J Pediatr       Date:  1975-12-09       Impact factor: 3.183

7.  Hypertrophic scarring is the usual outcome of non-membranous aplasia cutis of the scalp.

Authors:  Stefano Cambiaghi; Laura Maffeis; Lucia Restano; Carlo Gelmetti
Journal:  Pediatr Dermatol       Date:  2009 May-Jun       Impact factor: 1.588

8.  The effect of beta-receptor-stimulating agents on the utero-placental blood flow.

Authors:  S Elnäs; I Joelsson; R Lewander; H Lundqvist; N O Lunell; B Sarby; H Aström
Journal:  Acta Obstet Gynecol Scand       Date:  1977       Impact factor: 3.636

9.  Symmetric truncal aplasia cutis congenita following multifetal reduction of a sextuplet pregnancy.

Authors:  Julie V Schaffer; Dorota A Popiolek; Seth J Orlow
Journal:  J Pediatr       Date:  2008-12       Impact factor: 4.406

10.  The role of diclofenack on inducing of aplasia cutis congenita: a case report.

Authors:  Laura Pajaziti; Syzana Rexhepi; Ylfete Shatri-Muça; Mybera Ferizi
Journal:  Cases J       Date:  2009-10-12
View more
  3 in total

1.  Extreme aplasia cutis congenita involving the skull.

Authors:  Sebastian Shrager; Vlad Voin; Joe Iwanaga; R Shane Tubbs; James Johnston
Journal:  Childs Nerv Syst       Date:  2017-05-05       Impact factor: 1.475

2.  Aplasia cutis congenita: A case report and literature review.

Authors:  Xunhong Duan; G E Yang; Dongqi Yu; Changlong Yu; Biao Wang; Yibin Guo
Journal:  Exp Ther Med       Date:  2015-09-09       Impact factor: 2.447

3.  Aplasia Cutis Congenita in a Newborn: A Rare Case.

Authors:  Aditya Pratap Singh; Arun Kumar Gupta; Rajlaxmi Pardeshi; Arvind Kumar Shukla
Journal:  J Indian Assoc Pediatr Surg       Date:  2018 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.